// App-Quantinova.ai

3056 : The Risk of Organ Specific Graft-Versus-Host Disease Can Be Predicted by the Multiple Single Nucleotide Polymorphism Based Predictive Models.

Researchers

Presenter

  • Hong-Hee Won

Principal Investigators

  • Wei Xu

  • Jieun Uhm

  • Vikas Gupta

  • Daniela Cilloni

  • John Kuruvilla

  • Hans A. Messner

  • Jeffrey H. Lipton

Medical Centers

  • Division of Medical Oncology and Hematology, Princess Margaret Hospital, University Health Network, Toronto, ON, Canada,

  • Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, ON, Canada

  • Department of Medical Oncology and Hematology, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Division of Medical Oncology, Princess Margaret Hospital/University of Toronto, Toronto, ON, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • Nitric oxide synthase 1

  • Platelet Derived Growth Factor C

  • Platelet Derived Growth Factor Receptor Beta

  • Cluster of differentiation 95

  • Endothelin-1

  • Interleukin 12A

  • Interleukin 4

  • Transforming growth factor beta

  • Transforming Growth Factor Beta Receptor 1

  • Transforming Growth Factor Beta 1

Drug/Treatment

  • Becaplermin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved